tradingkey.logo

CorMedix Inc <CRMD.OQ> expected to post earnings of 13 cents a share - Earnings Preview

ReutersMar 7, 2025 1:15 PM
  • CorMedix Inc CRMD.OQ CRMD.O is expected to show a rise in quarterly revenue when it reports results on March 10 (estimated) for the period ending December 31 2024

  • The Berkeley Heights New Jersey-based company is expected to report revenue of $25.414 million, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on January 7 2025, for the period ended December 31, was for revenue of $31.000 million.

  • ​LSEG's mean analyst estimate for CorMedix Inc is for earnings of 13 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for CorMedix Inc is $17.00​, above​ its last closing price of $9.49. ​​​

The company's guidance on January 7 2025 for the period ended December 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of of USD12 million.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.10

-0.10

-0.05

Beat

51.3

Jun. 30 2024

-0.24

-0.25

-0.25

Met

0

Mar. 31 2024

-0.27

-0.28

-0.25

Beat

9.9​

Dec. 31 2023

-0.20

-0.20

-0.26

Missed

-28.9

​​Sep. 30 2023

-0.20

-0.21

-0.17

Beat

18.2

Jun. 30 2023

-0.23

-0.24

-0.25

Missed

-3.6​

Mar. 31 2023

-0.20

-0.20

-0.24

Missed

-20

Dec. 31 2022

-0.19

-0.20

Missed

-7

This summary was machine generated March 7 at 13:15 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI